Skip to main content
    P

    Processa Pharmaceuticals Inc (PCSA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.68
    +0.07 (+4.02%)

    Market Cap: $5.31M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    38%(8/21)
    Avg Surprise
    -19.58%
    Streak
    1 Q
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 14
    		$-1.19N/AN/ABeat-60.8%
    Sep 25
    Reported Nov 6
    		$-1.75$-2.00+12.50%Beat+93.2%
    Jun 25
    Reported Aug 7
    		$-0.25$-0.23-8.70%Miss+99.0%
    Mar 25
    Reported May 8
    		$-7.50N/A+61.04%Beat+73.0%
    Dec 24
    Reported Mar 20
    		$-0.74$-0.92+19.57%Beat+56.5%
    Sep 24
    Reported Oct 30
    		$-25.75$-25.00-3.00%Miss+35.6%
    Jun 24
    Reported Aug 13
    		$-25.25$-24.50-3.06%Miss+49.5%
    Mar 24
    Reported May 10
    		$-27.75$-29.50+5.93%Beat-15316.7%
    Dec 23
    Reported Mar 29
    		$-1.70$-1.60-6.25%Miss+99.0%
    Sep 23
    Reported Nov 13
    		$-40.00$-50.00+20.00%Beat+78.4%
    Jun 23
    Reported Aug 10
    		$-50.00$-75.00+33.33%Beat+68.8%
    Mar 23
    Reported May 15
    		$-0.18$-0.28+35.71%Beat+99.8%
    Dec 22
    Reported Mar 30
    		$-175.00$-152.50-14.75%Miss-83233.3%
    Sep 22
    Reported Nov 8
    		$-185.00$-167.50-10.45%Miss-94.7%
    Jun 22
    Reported Aug 12
    		$-160.00$-95.00-68.42%Miss-60.0%
    Mar 22
    Reported May 12
    		$-100.00$-106.67+6.25%Beat-42.9%
    Dec 21
    Reported Mar 30
    		$-0.21$-0.19-10.53%Miss+87.6%
    Sep 21
    Reported Nov 12
    		$-95.00$-92.50-2.70%Miss+4.8%
    Jun 21
    Reported Aug 12
    		$-100.00$-70.00-42.86%Miss-76823.1%
    Mar 21
    Reported May 13
    		$-70.00$-55.00-27.27%Miss-43650.0%
    Dec 20
    Reported Mar 25
    		$-1.69$-0.35-382.86%Miss-634.8%
    Sep 20
    Reported Nov 12
    		$-99.75$-80.00-24.69%Miss-62243.8%
    Jun 20
    Reported Aug 5
    		$-0.13N/AN/ABeat+27.8%
    Mar 20
    Reported May 15
    		$-0.16N/AN/ABeat+94.1%
    Dec 19
    Reported Mar 6
    		$-0.23N/AN/ABeat+89.6%
    Sep 19
    Reported Nov 14
    		$-0.16N/AN/ABeat+94.8%
    Jun 19
    Reported Aug 14
    		$-0.18N/AN/ABeat+96.1%
    Mar 19
    Reported May 14
    		$-2.72N/AN/ABeat+37.6%
    Dec 18
    Reported Mar 28
    		$-2.21N/AN/ABeat-
    Sep 18
    Reported Nov 13
    		$-3.09N/AN/ABeat-
    Jun 18
    Reported Aug 14
    		$-4.61N/AN/ABeat-
    Mar 18
    Reported Apr 16
    		$-4.35N/AN/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-464.20%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio0.87xQuick Ratio0.87x
    Trading Statistics
    Beta1.20Avg Volume177.84K
    52-Week High$11.0052-Week Low$1.04

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.59
    SMA 20$1.70
    SMA 50$1.98
    SMA 200$2.44
    EMA 10$1.65
    EMA 20$1.71
    EMA 50$1.90
    EMA 200$2.80

    MACD

    Line: -0.09Signal: -0.12Hist: 0.03

    ADX

    ADX: 16.3+DI: 20.0-DI: 21.8

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down84.0
    PSAR$1.15

    Bollinger Bands

    Upper Band$2.06
    Lower Band$1.34
    %B Position4187%(Upper)
    Band Width0.47

    RSI (14-Day)

    Neutral
    47.0

    Momentum Oscillators

    Stoch %K68.9
    Stoch %D72.8
    Williams %R-31.9
    ROC (10d)3.7%
    Momentum0.06
    CCI (20d)-28.7
    MFI (14d)93.5

    Volatility Measures

    ATR (14d)$0.21(12.3%)
    StdDev (20d)0.18
    Hist Vol124.7%(High)

    Volume Flow

    VWAP$1.64
    OBV1.2B
    AD Line401.3B
    CMF (20d)0.137

    Volume Metrics

    Avg Vol (20d)193.7K
    Vol Ratio0.2x(Low)
    VWMA (20d)$1.58

    Pivot Points

    R3$1.91
    R2$1.83
    R1$1.72
    Pivot Point$1.64
    S1$1.53
    S2$1.45
    S3$1.34

    Advanced Oscillators

    TSI-15.27
    Ultimate Osc49.8
    KST-199.48

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$12.47M$0$0$0$0$0
    Cost of Revenue$0$0$301$0$0$0$301$0$0$0$140$0
    Gross Profit$0$0$-301$0$0$0$-301$0$0$0$-140$0
    Operating Expenses$2.34M$3.33M$3.70M$3.49M$3.95M$2.85M$2.73M$3.42M$3.08M$2.81M$2.47M$2.17M
    R&D$649,877$1.81M$2.11M$1.66M$2.45M$1.59M$1.71M$2.29M$1.73M$1.54M$1.33M$1.15M
    SG&A$1.69M$1.52M$1.59M$1.83M$1.50M$1.26M$1.02M$1.14M$1.35M$1.27M$1.14M$1.02M
    Operating Income$-2,336,138$-3,331,214$-3,701,889$-3,488,843$-3,950,783$-2,846,990$-2,734,731$-3,424,853$-3,082,024$-2,809,598$-2,469,449$-2,167,612
    Interest Income$-2,003$13,859$0$0$8,862$12,585$0$0$0$0$0$85,661
    Interest Expense$929,356$45,965$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-3,265,494$-3,377,179$-3,289,803$-3,488,843$-3,941,921$-2,834,405$-2,616,860$-3,424,853$-3,082,024$-2,726,381$-2,404,931$-2,081,951
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-3,265,494$-3,377,179$-3,358,938$-3,436,573$-3,933,918$-2,834,405$-2,728,708$-3,384,703$-3,010,326$-2,726,381$-2,404,931$-2,081,951
    EBITDA$-3,263,190$-3,390,737$-3,701,588$-3,488,542$-3,950,482$-2,846,689$-2,734,430$-3,424,650$-3,081,885$-2,726,242$-2,469,309$-2,167,530
    EBIT$-3,263,491$-3,391,038$-3,701,889$-3,488,843$-3,950,783$-2,846,990$-2,734,731$-3,424,853$-3,082,024$-2,726,381$-2,469,449$-2,167,612
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PCSA

    News

    Processa Pharmaceuticals Company Profile & Introduction

    This document provides a company profile and introduction for Processa Pharmaceuticals. No further details are available in the provided content.

    Moomoo•10/13/26•Neutral

    Processa Pharmaceuticals Inc (PCSA-Q) Stock Price and News

    This page provides real-time stock price and news updates for Processa Pharmaceuticals Inc. (PCSA-Q), including recent corporate actions like shareholder approvals, acquisitions, leadership changes...

    The Globe and Mail•10/11/26•Neutral

    Form PRE 14A Processa Pharmaceuticals Inc For: 9 October By Investing.com

    The article reports that Processa Pharmaceuticals Inc. filed Form PRE 14A on October 9. It is a very brief news item primarily indicating a regulatory filing by the company. The rest of the content includes market data...

    Investing.com Canada•10/9/26•Neutral

    Form PRE 14A Processa Pharmaceuticals Inc For: 9 October By Investing.com

    Investing.com published a PRE 14A form for Processa Pharmaceuticals Inc., dated October 9. The article provides the title of the filing and its publication details.

    Investing.com Nigeria•10/9/26•Neutral

    Processa Pharmaceuticals files prospectus for 306.574M share sale

    Processa Pharmaceuticals Inc. has filed a prospectus with the SEC for a secondary offering of 306.574 million common shares. This offering is being conducted by existing shareholders who are looking to sell their...

    scanx.trade•10/9/26•Neutral

    PCSA Valuation and Fair Value

    P/B
    -14.6x
    See GNG's fair value

    PCSA Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -464.2%

    PCSA Competitors

    CompanyTicker
    Volitionrx LtdVNRX
    Aptorum Group Ltd Class AAPM
    Scienture Holdings, Inc.SCNX
    Trinity Biotech plcTRIB
    Longeveron LLCLGVN
    Icecure MedicalICCM
    enVVeno Medical CorpNVNO
    Pulmatrix IncPULM

    Sector: Healthcare

    PCSA Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    9.8%

    Frequently Asked Questions About PCSA

    Does PCSA pay dividends?

    Processa Pharmaceuticals Inc (PCSA) does not currently pay a regular dividend.

    What is PCSA's market cap?

    Processa Pharmaceuticals Inc (PCSA) has a market capitalization of $5.31M with a current stock price of $1.68.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In